225 related articles for article (PubMed ID: 23112017)
1. Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review.
Tan WK; Lim SK; Tan LK; Bauptista D
Singapore Med J; 2012 Oct; 53(10):659-63. PubMed ID: 23112017
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
3. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome.
Di Nisio M; Peters L; Middeldorp S
Cochrane Database Syst Rev; 2005 Apr; (2):CD004734. PubMed ID: 15846729
[TBL] [Abstract][Full Text] [Related]
6. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
Potdar N; Gelbaya TA; Konje JC; Nardo LG
Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
[TBL] [Abstract][Full Text] [Related]
8. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
[TBL] [Abstract][Full Text] [Related]
10. Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia.
Karadağ C; Yoldemir T; Karadağ SD; İnan C; Dolgun ZN; Aslanova L
Ir J Med Sci; 2017 Aug; 186(3):707-713. PubMed ID: 28176193
[TBL] [Abstract][Full Text] [Related]
11. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
[TBL] [Abstract][Full Text] [Related]
12. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
13. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
[No Abstract] [Full Text] [Related]
14. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].
Paskaleva I; Karagiozova Zh; Doncheva E; Dineva D
Akush Ginekol (Sofiia); 2014; 53(2):3-10. PubMed ID: 25098102
[TBL] [Abstract][Full Text] [Related]
16. Outcome of pregnancies in women with thrombophilic disorders.
Sucak A; Acar K; Celen S; Danisman N; Sucak GT
J Obstet Gynaecol; 2010; 30(8):847-51. PubMed ID: 21126128
[TBL] [Abstract][Full Text] [Related]
17. Inherited thrombophilia: treatment during pregnancy.
De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta-analysis.
Chen Y; Wang T; Liu X; Ye C; Xing D; Wu R; Li F; Chen L
J Obstet Gynaecol Res; 2022 Aug; 48(8):2134-2150. PubMed ID: 35661489
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
Weintraub AY; Sheiner E
Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
[TBL] [Abstract][Full Text] [Related]
20. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME.
Sokol V; Ivanišević M; Herman M; Đelmiš J
Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
